4-butyrolactone has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flaherty, S; Reynolds, JM; Sharma-Walia, N; Woodman, KM; Young, KE | 1 |
| Gershwin, ME; Kurimoto, Y; Naiki, M; Suehiro, S; Takeoka, Y; Yago, H | 1 |
2 other study(ies) available for 4-butyrolactone and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Fatty acid synthase regulates the pathogenicity of Th17 cells.
Topics: 4-Butyrolactone; Animals; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Gene Expression Regulation; Humans; Interferon-gamma; Interleukin-17; Interleukin-23; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Primary Cell Culture; Signal Transduction; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Toll-Like Receptor 2 | 2017 |
2-Buten-4-olide (2-B4O) inhibits experimental allergic encephalomyelitis (EAE) in Lewis rats.
Topics: 4-Butyrolactone; Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Immunosuppressive Agents; Lymphocyte Activation; Myelin Basic Protein; Peptide Fragments; Rats; Rats, Inbred Lew; T-Lymphocytes | 1995 |